Richard K Zimmerman1, G K Balasubramani2, Helen E A D'Agostino2, Lloyd Clarke3, Mohamed Yassin4, Donald B Middleton5, Fernanda P Silveira6, Nicole D Wheeler7, Jonathan Landis7, Alanna Peterson8, Joe Suyama9, Alexandra Weissman9, Mary Patricia Nowalk1. 1. Department of Family Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 2. Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA. 3. Department of Pharmacy, Division of Infectious Diseases/Pharmacy Department, UPMC Health System, Pittsburgh, PA, USA. 4. Infection Control Department, UPMC Mercy Hospital, Pittsburgh, PA, USA. 5. Department of Medical Education, UPMC St. Margaret Hospital, Pittsburgh, PA, USA. 6. Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 7. Department of Emergency Medicine, UPMC Passavant Hospital, Pittsburgh, PA, USA. 8. Department of Emergency Medicine, UPMC Shadyside Hospital, Pittsburgh, PA, USA. 9. Department of Emergency Medicine, UPMC Magee-Women's Hospital, Pittsburgh, PA, USA.
Abstract
BACKGROUND: Acute respiratory infections (ARIs) result in millions of illnesses and hundreds of thousands of hospitalizations annually in the United States. The responsible viruses include influenza, parainfluenza, human metapneumovirus, coronaviruses, respiratory syncytial virus (RSV), and human rhinoviruses. This study estimated the population-based hospitalization burden of those respiratory viruses (RVs) over 4 years, from July 1, 2015 to June 30, 2019, among adults ≥18 years of age for Allegheny County (Pittsburgh), Pennsylvania. METHODS: We used population-based statewide hospital discharge data, health system electronic medical record (EMR) data for RV tests, census data, and a published method to calculate burden. RESULTS: Among 26,211 eligible RV tests, 67.6% were negative for any virus. The viruses detected were rhinovirus/enterovirus (2552; 30.1%), influenza A (2,299; 27.1%), RSV (1082; 12.7%), human metapneumovirus (832; 9.8%), parainfluenza (601; 7.1%), influenza B (565; 6.7%), non-SARS-CoV-2 coronavirus (420; 4.9% 1.5 years of data available), and adenovirus (136; 1.6%). Most tests were among female (58%) and White (71%) patients with 60% of patients ≥65 years, 24% 50-64 years, and 16% 18-49 years. The annual burden ranged from 137-174/100,000 population for rhinovirus/enterovirus; 99-182/100,000 for influenza A; and 56-81/100,000 for RSV. Among adults <65 years, rhinovirus/enterovirus hospitalization burden was higher than influenza A; whereas the reverse was true for adults ≥65 years. RV hospitalization burden increased with increasing age. CONCLUSIONS: These virus-specific ARI population-based hospital burden estimates showed significant non-influenza burden. These estimates can serve as the basis for several areas of research that are essential for setting funding priorities and guiding public health policy.
BACKGROUND: Acute respiratory infections (ARIs) result in millions of illnesses and hundreds of thousands of hospitalizations annually in the United States. The responsible viruses include influenza, parainfluenza, human metapneumovirus, coronaviruses, respiratory syncytial virus (RSV), and human rhinoviruses. This study estimated the population-based hospitalization burden of those respiratory viruses (RVs) over 4 years, from July 1, 2015 to June 30, 2019, among adults ≥18 years of age for Allegheny County (Pittsburgh), Pennsylvania. METHODS: We used population-based statewide hospital discharge data, health system electronic medical record (EMR) data for RV tests, census data, and a published method to calculate burden. RESULTS: Among 26,211 eligible RV tests, 67.6% were negative for any virus. The viruses detected were rhinovirus/enterovirus (2552; 30.1%), influenza A (2,299; 27.1%), RSV (1082; 12.7%), human metapneumovirus (832; 9.8%), parainfluenza (601; 7.1%), influenza B (565; 6.7%), non-SARS-CoV-2 coronavirus (420; 4.9% 1.5 years of data available), and adenovirus (136; 1.6%). Most tests were among female (58%) and White (71%) patients with 60% of patients ≥65 years, 24% 50-64 years, and 16% 18-49 years. The annual burden ranged from 137-174/100,000 population for rhinovirus/enterovirus; 99-182/100,000 for influenza A; and 56-81/100,000 for RSV. Among adults <65 years, rhinovirus/enterovirus hospitalization burden was higher than influenza A; whereas the reverse was true for adults ≥65 years. RV hospitalization burden increased with increasing age. CONCLUSIONS: These virus-specific ARI population-based hospital burden estimates showed significant non-influenza burden. These estimates can serve as the basis for several areas of research that are essential for setting funding priorities and guiding public health policy.
Authors: Jeffrey C Kwong; Kevin L Schwartz; Michael A Campitelli; Hannah Chung; Natasha S Crowcroft; Timothy Karnauchow; Kevin Katz; Dennis T Ko; Allison J McGeer; Dayre McNally; David C Richardson; Laura C Rosella; Andrew Simor; Marek Smieja; George Zahariadis; Jonathan B Gubbay Journal: N Engl J Med Date: 2018-01-25 Impact factor: 91.245
Authors: Richard K Zimmerman; Charles R Rinaldo; Mary Patricia Nowalk; G K Balasubramani; Krissy K Moehling; Arlene Bullotta; Heather F Eng; Jonathan M Raviotta; Theresa M Sax; Stephen Wisniewski Journal: BMC Infect Dis Date: 2015-02-22 Impact factor: 3.090
Authors: Richard K Zimmerman; Charles R Rinaldo; Mary Patricia Nowalk; G K Balasubramani; Mark G Thompson; Arlene Bullotta; Michael Susick; Stephen Wisniewski Journal: Adv Virol Date: 2014-12-09
Authors: Ting Shi; Andrew Arnott; Indre Semogas; Ann R Falsey; Peter Openshaw; Jadwiga A Wedzicha; Harry Campbell; Harish Nair Journal: J Infect Dis Date: 2020-10-07 Impact factor: 5.226
Authors: Nelson Lee; Stephanie Smith; Nathan Zelyas; Scott Klarenbach; Lori Zapernick; Christian Bekking; Helen So; Lily Yip; Graham Tipples; Geoff Taylor; Samira Mubareka Journal: CMAJ Date: 2021-03-29 Impact factor: 8.262
Authors: G K Balasubramani; Mary Patricia Nowalk; Heather Eng; Richard K Zimmerman Journal: Hum Vaccin Immunother Date: 2022-12-31 Impact factor: 3.452
Authors: Richard K Zimmerman; G K Balasubramani; Helen E A D'Agostino; Lloyd Clarke; Mohamed Yassin; Donald B Middleton; Fernanda P Silveira; Nicole D Wheeler; Jonathan Landis; Alanna Peterson; Joe Suyama; Alexandra Weissman; Mary Patricia Nowalk Journal: Influenza Other Respir Viruses Date: 2022-08-22 Impact factor: 5.606